Loading provider…
Loading provider…
Surgery Physician in New York, NY
NPI: 1558352245Primary Employer
Mskcc Surgery Group
mskcc.org
HQ Phone
Get MD Mary's Phone Numberphone_androidMobile
Get MD Mary's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1985 - 2026
NJ State Medical License
2023 - 2025

American Board of Surgery
Surgery
Memorial Sloan Kettering Cancer Center
Post-Doctoral Fellowship • Complex General Surgical Oncology
1988 - 1992
New York Presbyterian Hospital (Cornell Campus)
Residency • Surgery
1989 - 1990
Residency • Surgery
1983 - 1988
Internship • Surgery
1983 - 1984
University of Miami, Miller School of Medicine
med.miami.edu
Medical School
Until 1983
Memorial Sloan-Kettering
Until 1990
University of Colorado Boulder
BA • English
1974 - 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99212Established patient outpatient visit, total time 10-19 minutes | 102 | 124 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 74 | 74 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 50 | 50 |
| 4 | 99202New patient office or other outpatient visit, typically 20 minutes | 25 | 25 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 25 | 26 |
Authors: Mariana Berho, Peter Blumencranz
Journal: J Surg Oncol
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Ipilimumab, Melphalan and Dactinomycin
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: BEHAVIORAL: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: melphalan, BIOLOGICAL: dactinomycin, DRUG: isolated limb perfusion